Ecots Bio Products Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.34 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.60 M
as on 16-11-2024
- Revenue 41.17%
(FY 2023)
- Profit -1451.97%
(FY 2023)
- Ebitda -188.79%
(FY 2023)
- Net Worth -13.22%
(FY 2023)
- Total Assets -2.71%
(FY 2023)
About Ecots Bio Products
The Corporate was formerly known as Ecots Sancta Coir Products Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.34 Cr. The company has closed loans amounting to ₹4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Srihari Shanthi and Srihari Ratnam serve as directors at the Company.
- CIN/LLPIN
U17233TZ2000PTC009300
- Company No.
009300
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ecots Bio Products Private Limited offer?
Ecots Bio Products Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Organic Fertilizers and Manure, Coir Products, Coir Pith, Agricultural Bags, Coco Peat Grow Bag, Carrier Oil, Neem Oil, Coal, Carbon & Charcoal, Charcoal.
Who are the key members and board of directors at Ecots Bio Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srihari Shanthi  | Managing Director | 11-Apr-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srihari Ratnam | Director | 11-Apr-2000 | Current |
Financial Performance of Ecots Bio Products.
Ecots Bio Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.17% increase. The company also saw a substantial fall in profitability, with a 1451.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ecots Bio Products?
In 2023, Ecots Bio Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 11 Nov 2005 | ₹1.34 Cr | Open |
Canara Bank Creation Date: 24 Jun 2003 | ₹4.60 M | Satisfied |
How Many Employees Work at Ecots Bio Products?
Unlock and access historical data on people associated with Ecots Bio Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ecots Bio Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ecots Bio Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
